Depression in patients with cardiovascular disease
Authors:
V. Pidrman
Authors place of work:
Privátní psychiatr, Galenus, Hradec Králové
Published in the journal:
Kardiol Rev Int Med 2010, 12(1): 15-18
Summary
The author describes the association between depression and cardiovascular disease. He emphasizes the direct link between these two groups of disorders (not only from the psychological point of view but also with respect to their biological basis). He describes suitable antidepressant therapy for cardiovascular patients. Correct antidepressants should be save and efficacious in acute therapy as well as in long‑term treatment. SSRI antidepressants are still the first step in depression therapy of these risk cardiovascular patients today.
Key words:
depression – antidepressants – SSRI – cardiovascular disease
Zdroje
1. Gottfried CG, Karlsson I. Depression in later life. Oxford: OCC 1997.
2. Spar EJ, La Rue A. Concise guide to geriatric psychiatry. Washington: American Psychiatric Publishing 2002.
3. Thorpe L, Whitney DK, Kutcher SP et al. CANMAT Depression Work Group. Clinical Guidelines for the treatment of depressive disorders. VI. Special populations. Canadian Journal of Psychiatry 2001; 46: 63S– 76S.
4. Braunwald E. Harisson’s principles of internal medicine. New York: McGraw‑ Hill Book Company 1998.
5. McIntyre JS, Charles SC, Anzia DJ et al. American Psychiatric Association Steering Committee on Practice Guidelines. American Psychiatric Association: Practice Guidelines for the Treatment of Psychiatric Disorders. Compendium 2006. Arlington: American Psychiatric Association 2006.
6. Goodyer JM. Unipolar depression. New York: Oxford University Press 2003.
7. Malhi GS, Bridges PK. Management of depression. London: Marin Dunitz 1998.
8. Murray CJL, Lopez AD (eds). The global burden of disease. Cambridge: Harvard University Press 1996.
9. Glassman AH, O’Connor CM, Califf RM et al. Sertraline treatment of major depression in patients with acute IM or unstable angina. JAMA 2002; 288: 701– 709.
10. Pidrman V. Deprese a kardiovaskulární onemocnění. 3. vyd. Maxdorf 2004.
11. Bouček J, Pidrman V. Psychofarmaka v medicíně. Praha: Grada Publishing 2005.
12. Henn F, Sartorius N, Helmchen H et al. Contemporary psychiatry. Berlin: Springer 2001.
13. Preskorn SH. Outpatient management of depression. Caddo: Professional Communication 1999.
14. Reuben BD, Herr KA, Pacala JT et al. Geriatrics at your fingertips. Malden: Blackwell Publishing 2003.
15. Stahl MS. Essential psychopharmacology. Neurocsietntific basis and practical applications. Cambridge: Cambridge University Press 2002.
16. Alexopoulos GS, Katz IR, Reynolds CF et al. Pharmacotherapy of depressive disorders in older patients. New York: Comprehensive NeuroScience 2001.
17. Bazire S. Psychotropic drug directory 2002. Jesses Farm: Mark Alen Publishing 2006.
18. Cozza KL, Armstrong SC. The cytochrome P450 system. Drug interaction principles for medical practice. Washington, DC: American Psychiatric Publishing 2001.
19. Jacobson SA, Preis RW, Greenblatt DJ. Handbook of geriatric psychopharmacology. Washington, DC: American Psychiatric Publishing 2002.
20. Flint AJ, Rifat SL. Maintenance tretment for recurrent depression in late life: a four year outcome study. Am J Geriatr Psychiatry 2000; 8: 112– 116.
21. Roose SP, Spatz BS. Treating depression in patients with ischemic heart disease. Drug safety 1999; 20: 459– 465.
22. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2001; 104: 1894– 1898.
23. Shiloh R, Nutt D, Weizman A. Atlas of psychotropic pharmacotherapy. London: Martin Dunitz 2000.
24. Schaltberg AF, Cole JO, DeBatista C. Manual of clinical psychopharmacology. Washington, DC: American Psychiatric Publishing 2003.
25. Solai LK, Mulsant BH, Pollock BG. Selective serotonin reuptake inhibitors for late‑life depression: a comparative review. Drug Aging 2001; 18: 355– 368.
Štítky
Paediatric cardiology Internal medicine Cardiac surgery CardiologyČlánok vyšiel v časopise
Cardiology Review
2010 Číslo 1
Najčítanejšie v tomto čísle
- Carvedilol as a treatment option for cardiovascular diseases
- Depression in patients with cardiovascular disease
- Tenecteplase in current clinical practice
- New players on the antiplatelet therapy chequerboard – what can we expect?